OPKO Health, Inc.
$1.50B- Market cap
- $1.18B
- Debt
- +$687.93M
- Cash
- −$364.41M
Capital structure 63% equity / 37% debt · EV / Revenue 2.48x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt cap
Decision snapshot: OPK stock price at discount vs VSAT $1.58 current versus $1.91 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VSAT's multiple
Implied fair value · at OPK's multiple
Snapshot Sep 8, 2026, 1:53 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: OPK FY 2025 (ended Dec 31, 2025) · VSAT FY 2026 (ended Mar 31, 2026). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 63% equity / 37% debt · EV / Revenue 2.48x
Capital structure 63% equity / 37% debt · EV / Revenue 3.36x · EV / EBITDA 7.34x
VSAT carries the larger enterprise value at $15.59B against $1.50B; OPK trades on the lower EV / Revenue multiple (2.48x vs 3.36x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
OPKO Health, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
VIASAT, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.54x
1.38x
Net debt / EBITDA
Leverage against operating earnings
-3.03x
2.21x
Cash and equivalents
Liquid reserves on the balance sheet
$364.41M
$1.75B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMARIN CORP PLC\UK
OPK vs AMRN
Sarepta Therapeutics, Inc.
OPK vs SRPT
Amphastar Pharmaceuticals, Inc.
OPK vs AMPH
SUPERNUS PHARMACEUTICALS, INC.
OPK vs SUPN
Harmony Biosciences Holdings, Inc.
OPK vs HRMY
COMTECH TELECOMMUNICATIONS CORP /DE/
OPK vs CMTL
GILAT SATELLITE NETWORKS LTD
OPK vs GILT
Spire Global, Inc.
OPK vs SPIR
Iridium Communications Inc.
OPK vs IRDM
L3HARRIS TECHNOLOGIES, INC. /DE/
OPK vs LHX
KVH INDUSTRIES INC \DE\
OPK vs KVHI
$687.93M
$6.45B
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.